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Introduction: To investigate the connection between the intensity of initial symptoms of inflammation and locomotor
outcome in rheumatoid arthritis, we examined the relationship between long-term locomotor abnormalities and signs
of inflammation at the onset of the disease in adjuvant-induced arthritis (AIA) in rats.
Methods: The arthritis score and hind-paw diameter were followed from immunization to day 195 (~7 months). At
this time, locomotion was recorded during forced treadmill walking using 3D motion technology before radiographic
scoring of hind limb joint damage. Many locomotor parameters were analyzed including time and length parameters,
limbs kinematics, lateral paw position at toe off, maximal hind-paw elevation and posture. Ankle mobility was assessed
from range of motion (ROM) of the joint during locomotion. Experiments were run in AIA (n = 18) and age-matched
non-AIA rats (n = 8).
Results: All AIA rats exhibited signs of inflammation at day 14 with a peak of inflammatory symptoms at day 22
post-immunization. After the first episode of inflammation, 83 % of AIA rats demonstrated recurrent disease (from week
6 to week 23). The frequency of inflammatory episodes (1 to 5) was not linked to the arthritis score at day 22. At day
195 post-immunization, AIA rats showed significantly impaired locomotion and radiographic lesions as compared to
control rats. Significant relationships were observed between most locomotion-related parameters and concurrent
ROM of ankle, which correlated negatively with the radiographic score. ROM of ankle at day 195 correlated negatively
with both the arthritis score and hind-paw diameter measured at day 14, 22 and 30 post-immunization.
Conclusion: Decreased ankle mobility can be considered a driver of locomotion impairment in AIA. In this model, the
severity of the initial inflammatory symptoms had a good prognostic value for long-term locomotor outcome.Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory
autoimmune disease that affects about 1 % of the general
population in Western countries. RA is characterized by
symmetric joint involvement that can range from a
monoarticular to a highly polyarticular pattern and joint
damage that can span from mild cartilage degradation to
progressive erosive disease of juxta-articular bone.
Therefore, although RA is still regarded as a single dis-
order, the impact of RA on motor disability and decreased
quality of life varies considerably among individuals. The* Correspondence: chmarie@u-bourgogne.fr
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impairment but it is still unclear whether locomotor alter-
ations are due to pain, limited range of motion (ROM) in
the joint, loss of functional balance or muscle loss [1–4].
Currently, there is no reliable (either biological or clinical)
prognostic factor in RA, yet information on the likely out-
come of RA would help therapeutic decision-making [5].
Although there is a consensus for the efficient control of
inflammation at the onset and throughout the course of
the disease as the main way to reduce functional decline
in RA patients [6], it is unknown whether the functional
outcome is influenced by the intensity of initial inflamma-
tory symptoms.
Adjuvant-induced arthritis (AIA) in rats is one of the
most widely used animal models of RA and is predictive
of the clinical efficacy of many drugs in human RA [7].rticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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episode of inflammation peak within 2 to 3 weeks after
immunization and then progressively resolve. However,
even though all immunized rats share a similar time-
course of the disease, they differ from each other by the
severity of the initial inflammatory symptoms. Therefore,
AIA in rats offers the unique opportunity to explore the
connection between the severity of initial inflammation
and functional outcome. As a hallmark of AIA in rats is
bilateral ankle damage [8], locomotion analysis seems to
be an appropriate tool to assess motor disabilities. Not-
ably, in previous studies aimed at investigating locomo-
tion in animal models of mono- and polyarthritis,
locomotion analysis was restricted to the acute inflam-
matory period of the disease [9–16].
The present study examined the prognostic value of
the severity of the initial inflammation on locomotor
outcome in AIA rats. For this purpose, we explored the
relationships between locomotor parameters measured
at day 195 (approximately 7 months) post-immunization
and the arthritis score or hind-paw diameter measured
early during the initial inflammatory period. Multiple
locomotor parameters including time and length param-
eters, limb kinematics, lateral paw position at toe-off,
maximal hind-paw elevation, posture, and ROM of the
ankle were measured using 3D imaging technology.
Radiographic images of the hind paws were taken and
scored just after the locomotion recording. AIA and age-
matched non-AIA rats were studied in parallel.
Methods
Animals
Six-week-old male Lewis rats (n = 38) were purchased
from Janvier (Le Genest Saint Isle, France). The animals
were kept under a 12 h-12 h light:dark cycle and allowed
free access to food and water. The experimental proce-
dures were approved by the local committee for ethics
in animal experimentation (#0411, date 01/18/2011) of
Université de Bourgogne (Dijon, France), and complied
with the Animal Research Reporting In vivo Experiments
(ARRIVE) guidelines. The same operator performed all
steps of the experiments (license number 21CAE035).
Selection of animals
All the rats were first handled gently for a few days and fa-
miliarized with the treadmill apparatus (Bioseb, Vitrolles,
France) in order to reduce stress due to novelty. Then,
they were selected according to their ability to walk re-
gularly on a horizontal treadmill with the speed of the
treadmill belt fixed at 30 cm/s. Three 30-second running
sessions were given twice a day for seven days. Mild inten-
sity electric shocks to the feet were used as negative
reinforcement to improve performance. Rats that failed to
walk in a regular manner on the treadmill (contact of theforelimbs with the front wall of the treadmill, frequent im-
mobility or galloping) at the end of the selection period
were excluded from further experiments. Of the 38 Lewis
rats enrolled in the study, 32 were able to walk in a regular
manner on the treadmill. These rats were divided into
AIA rats (n = 23) and control rats (n = 9).
Induction of arthritis
AIA was induced under volatile anesthesia (halothane)
by a single intradermal injection at the base of the tail of
1 mg of heat-killed Mycobacterium butyricum (Difco,
Detroit, MI, USA) suspended in 0.1 ml of Freund’s in-
complete adjuvant (Difco). A group of non-arthritic age-
matched rats received an equal volume of saline and
were used as control rats. The incidence of arthritis as
assessed from clinical scoring reached 91 % (21/23 im-
munized rats). Rats (n = 2) that did not develop arthritis
were excluded from further analysis.
Assessment of clinical signs of inflammation
The rats were weighed and monitored for clinical signs of
arthritis from immunization to week 27 (every two days
from day 9 to 80 and every 15 days from day 80 to 195).
The clinical scoring system (arthritis score) was employed
as follows [17]: one finger scores 0 (no arthritis) or 0.1
(redness or swelling of one finger) and each big joint
(ankle or wrist) scores 0 (no arthritis), 0.5 (mild but defin-
ite redness and swelling) or 1 (severe redness and intense
swelling). The tarsus and ankle was considered the same
joint. The arthritis score for a given limb ranged from 0 to
1.5 and the global arthritis score (four limbs) ranged from
0 to 6. The clinical scores were further divided into five
grades: grade 0 (arthritis score = 0), grade 1 (arthritis score
between 0.1 and 0.9), grade 2 (arthritis score between 1
and 1.9), grade 3 (arthritis score between 2 and 2.9), grade
4 (arthritis score between 3 and 3.9) and grade 5 (arthritis
score more than 4). As the arthritis score only provides a
subjective quantification of inflammation, it was coupled
with the measurement of hind paw diameter using a
digital caliper (Fischer Darex, France). The values were
expressed as the mean of the two hind paw diameters.
When indicated, values for individual hind paw diameters
were presented.
Radiographic analysis of hind paws
Radiographs of hind paws were performed at the end of
the experiment (week 27 after immunization) with a
BMA High Resolution Digital X-rays machine (40 mV,
10 mA) - D3A Medical Systems (Orléans, France). A
global score was determined for each hind paw using a
modification of the grading scale described by Esser
et al. [18]. This score evaluates both joint degradation,
which was assessed from joint space narrowing and ero-
sion, and new bone formation, which was assessed from
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scored at the tibiotalar, tarsal and subtalar joints as fol-
lows: normal aspect (0), mild degradation (1), moderate
degradation (2) and severe degradation (3). New bone for-
mation was scored at the calcaneum, tibia and tarsal bones
as follows: normal aspect (0), mild hyperostosis (1), moder-
ate hyperostosis (2) and severe hyperostosis (3). Radio-
graphs were rated by two independent experienced
observers. For each hind-paw, the maximal global radio-
graphic score was 18 while the maximal joint degradation
and the maximal new bone formation scores were both 9.
Locomotion recordings
Locomotion was recorded at week 25, 26 and 27 after
immunization and at corresponding times in controls.
Data were collected using the VICON MX-13 optical
motion capture system (Vicon, Oxford, Great Britain),
which consists of six high-speed digital infrared cameras
as previously described in detail by our laboratory
[19, 20]. Briefly, after anesthesia (intraperitoneal chloral
hydrate, 400 mg/kg) the four limbs and the back were
shaved and tattooed in order to locate the bony pro-
cesses. Twenty-two reflective hemispherical markers
(BTS Bioengineering, Cod FMK0005, Milano, Italy) with
a diameter of 6 mm were placed over the following ana-
tomical landmarks: the scapula, the upper (shoulder
marker) and lower (elbow marker) humerus epiphysis,
the metacarpophalangeal (MCP) joint, the iliac crest,
the great trochanter, the knee, the external malleolus
and the fifth metatarsophalangeal (MTP). Four markers
(markers 1, 2, 3 and 4) were also placed on the back
from the neck to the tail at regular distances. Three
arthritic rats and one control rats died from anesthesia
while being tattooed, thus, locomotion was recorded in
eighteen AIA rats and eight control rats. Locomotion
was recorded with the speed of the treadmill belt fixed
at 30 cm/s, a speed that is within the range of the
locomotion speed of rats over ground [21] and for a
1-minute session without delivering foot shocks. Soft
tissue movement around the knee (skin slippage) is a
recognized source of error when estimating joint kine-
matics of hind limbs in rats from markers placed on the
surface of the body overlying joints [22]. To investigate
this potential error, we measured the variation coeffi-
cient of the distance between the knee marker and the
external malleolus marker at toe contact and at toe-off
in both control and AIA rats.
Locomotion analysis
The gait cycle (defined as the time between two succes-
sive foot contacts of the same limb), was split into two
parts, the stance and the swing phase. The stance phase
was defined as the part of the cycle that begins when the
foot strikes the treadmill belt and terminates when thefoot starts its forward movement (i.e., when the vertical
velocity of the MTP markers was higher than a threshold
fixed at 5 % of its maximal velocity). The swing phase was
considered to begin at the onset of forward movement
and to end when the foot strikes the treadmill belt. Using
a MATLAB custom-program (Math-Works, Natick, MA,
USA), we measured the following locomotion-related pa-
rameters with a reference frame fixed to the hip marker:
– stance and swing phases duration, and gait cycle
duration
– stride length, which was computed as the Euclidian
distance (mm) of the more distal markers (MTP for
the hind-limbs, MTC for the fore-limbs) throughout
the swing phase
– maximal (Max) and minimal (Min) excursion of
joint angles (degrees) during the stance and the
swing phases
– paw location (mm) of the more distal marker of
limbs (MTP or MCP) at toe-off in the frontal plane
with respect to the axis passing through the hip for
the hind limbs and the shoulder for the fore-limbs.
A positive angular value indicates a paw placement
further to the side
– maximal paw elevation during the cycle (mm).
These parameters were calculated for each hemibody
in both control and AIA rats. For AIA rats, they were
calculated from the more and less impaired hemibody
(hemibody with the highest and lowest hind paw dia-
meter just before locomotor recording, respectively).
We also calculated the following parameters:
– ROM of lateral roll of the body (degrees). The
parameter was assessed from the measurement of
the lateral tilt angle between the horizontal plane of
the laboratory and the line passing through the two
hip markers
– sagittal tilt of the body (degrees). The parameter
was assessed from the measurement of the angle
between the horizontal plane of the laboratory and
the line passing through markers 1 and 4 of the
back. A negative angular value indicated elevation of
the hindquarter with respect to the head.
Even though all AIA rats were able to walk on the tread-
mill, periods with irregular locomotor cycles (walking on
only three limbs, successive jumps and short periods of
immobility followed by increased velocity of walking) were
more frequent in AIA than in control rats. In certain AIA
rats, the digits of the hind paws were often curled while
walking with no contact of the calcaneum with the tread-
mill belt. From a careful visual inspection of walking AIA
rats, we also detected hind-paw eversion. Unlike control
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servation of AIA rats in their housing cages revealed that
these rats avoided standing on their feet. It is noteworthy
that locomotion-related parameters were all calculated
from at least four regular and consecutive step cycles
during each trial in order to eliminate deviant curves [23].
Data and statistical analysis
Values are presented as the mean ± standard deviation ex-
cept for the data on recurrence of inflammatory episodes,
which were expressed by the median. Comparisons of
locomotion-related parameters between the left hemibody
of control rats and the two hemibodies of AIA rats were
made using the Kruskall Wallis’ test followed by the
Mann-Whitney t test and the Bonferroni correction. Dif-
ferences between the more and less impaired hemibodies
in AIA rats were assessed using Wilcoxon’s test for pair-
wise comparisons. The relationship between two variables
was investigated using the Pearson’s correlation coeffi-
cient. P <0.05 was considered statistically significant.
Results
Time course of arthritis scores and hind-paw diameters
in AIA
The results are summarized in Fig. 1. Arthritis was asso-
ciated with an early, long-lasting but reversible loss ofDays after immunization











































Fig. 1 Time course of arthritis. Body weights (a), global arthritis scores (b), an
and rats with adjuvant-induced arthritis (AIA) (n = 18) for 195 days after immu
with global arthritis scores at day (d) 14, 22 and 30 after immunization. Valuesbody weight (Fig. 1a). The first clinical signs of arthritis
were observed as early as day 10 after immunization. At
day 14, all AIA rats (n = 18) exhibited signs of inflam-
mation. The mean global arthritis score (Fig. 1b) peaked
at day 22 post-immunization (between days 20−24 post-
injection for 17 rats). At this time, the distribution of
rats according to the arthritis grade was as follows: 56 %
with grade 5, 28 % with grade 4, 11 % with grade 3 and
5 % with grade 2. The mean global arthritis score de-
creased abruptly from day 22 to day 60 and more pro-
gressively thereafter. Notably, all the limbs exhibited
clinical signs of arthritis even though signs were more
intense in the hind limbs than the forelimbs throughout
the disease. Hind-paw diameter (mm) in AIA rats was
5.8 ± 0.4 at day 9 (before the first signs of inflammation),
increased to 8.0 ± 1.1 at day 20, peaked at day 30 post-
immunization (8.4 ± 1.2) and then remained stable
(Fig. 1c). By contrast, mean hind-paw diameters in con-
trol rats did not change from day 9 to day 195 post-
immunization. Of note, the global arthritis score and
hind-paw diameter were highly correlated at days 14, 22
and 30 post-immunization, as shown in Fig. 1d. At day
195, the parameters were still correlated (r = 0.813, p =
2.10-5, not shown). Recurrent inflammatory disease (one
to five relapses) was observed in most AIA rats (15/18
rats, 83 %) within the period week 6 to week 23 post-Global arthritis score
























d30    r = 0.765  p = 10-4
d22    r = 0.789  p<10-5
d14    r = 0.869  p = 5.10-5
Days after immunization















d mean hind-paw diameters (c) were measured in control rats (n = 8)
nization. d In AIA rats, mean hind-paw diameters correlated positively
are means ± SD







Cycle duration (ms) 504 ± 16 485 ± 28 483 ± 29
Stance duration (ms) 376 ± 22 351 ± 34 361 ± 37
Swing duration (ms) 128 ± 12 134 ± 22 122 ± 18
Cycle length (mm) 80 ± 5 76 ± 8 81 ± 9
Fore-limbs
Cycle duration (ms) 506 ± 18 474 ± 39 473 ± 41a
Stance duration (ms) 324 ± 12 322 ± 27 309 ± 30
Swing duration (ms) 182 ± 12 152 ± 23a 164 ± 22
Cycle length (mm) 80 ± 8 76 ± 5 81 ± 10
Parameters were measured in control (n = 8) and adjuvant-induced arthritis
(AIA) rats (n = 18) at day 195 post-immunization. The more and less impaired
hemibodies corresponded to hemibodies with the highest and lowest
hind-paw diameter just before the locomotion recording, respectively.
Values are means ± SD. aSignificantly different from control rats (p <0.05)
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pared with the first episode of inflammation, inflamma-
tory signs related to relapses were weak and short
lasting (3 days). In addition, relapses did not occur at
the same time in the population of AIA rats, and as a re-
sult relapses could not be detected from the analysis of
the time course of the global arthritis score. Notably,
and consistent with the lack of a relationship between
the severity of the first episode of inflammation and re-
lapse frequency, the number of relapses expressed as a
median affected by minimal-maximal values was
2 (0−4) in rats with grade 5 (n = 10), 3 (2−4) in rats with
grade 4 (n = 5) and 3 (0−5) in rats with grade 2 or 3
(n = 3) at day 22 post-immunization, i.e., at the peak of
the global arthritis score.
Long-term AIA is associated with impaired locomotor
patterns and locomotion kinematics
Only locomotor parameters recorded at week 27 (day
195, approximately 7 months post-immunization) are
presented here because no difference was observed be-
tween the three recordings either in AIA or in control
rats. As visual examination of the hind limbs before the
first locomotion recording revealed bilateral but rela-
tively asymmetrical paw deformation in AIA rats, we
suspected asymmetrical impairment of locomotion pa-
rameters. Therefore, locomotor parameters for the hemi-
body with the highest and the lowest hind-paw diameter,
measured just before the first recording of locomotion,
were calculated separately. This diameter (mm) was 9.2
± 1.8 and 7.3 ± 1.4 for the more and less impaired hind-
limb, respectively (p <0.05). In control rats, locomotor
parameters were calculated from the left hemibody
(hind-paw diameter was 5.5 ± 1 mm).
Effect of arthritis on timing and length parameters
The results are shown in Table 1. Timing and length
parameters calculated from the hind limbs did not sig-
nificantly differ between control and AIA rats whatever
the hemibody considered. By contrast, the swing phase
of the forelimbs was shorter in AIA than in control rats
even though the reduction reached significance only for
the more impaired hemibody, thus resulting in a shorter
cycle duration of the fore-limbs in AIA rats (−6 % (not
statistically significant) for the more impaired hemibody
and –6 %, p <0.05 for the less impaired hemibody, as
compared to control values).
Effect of arthritis on joint angles
In accordance with our expectation that abnormalities in
kinematics could be asymmetrical in AIA rats, a diffe-
rence in joint angles was observed between the more
and less impaired hind limb except for the knee (Table 2).
The effects of AIA on hind limb kinematics were thatthe hip and knee were more flexed and the ankle more
extended in AIA than in control rats throughout the
cycle. The ROM of the ankle was quite different between
AIA and control rats during both the stance and swing
phase (Table 2). As compared to control values, the
ROM of the ankle in AIA rats during the stance phase
was decreased by 22 % (not significant) for the less im-
paired and by 45 % (p <0.05) for the more impaired
hemibody. The corresponding values during the swing
phase were 25 % (not significant) and 55 % (p <0.05).
Thus, stiffness of the ankles in AIA seemed to compel
the rats to keep the joint in extension throughout the
gait cycle. As regards the effect of AIA on fore limb
kinematics, comparison of the shoulder joint between
control and AIA rats suggested that the shoulder was
more extended in AIA during both the stance and swing
phase. By contrast, no difference was observed between
control and AIA rats at the elbow joint. The changes in
kinematics induced by arthritis are summarized in Fig. 2,
which shows angular excursion (Fig. 2a) and stick dia-
grams (Fig. 2b) in representative AIA and control rats.
Finally, no difference in the variation coefficient of the
knee-ankle distance was observed between the hind
limbs of control rats or between the less and more im-
paired hind limbs in AIA rats (not shown), thus indi-
cating that differences between control and AIA rats in
values for the knee joint and differences between the
hemibodies of AIA rats did not relate to skin slippage.
Effect of arthritis on paw location and posture
The results are summarized in Fig. 3. In control rats, paw
location at toe-off in the frontal plane was approximately






Joint angle during the stance phase (°)
Hip Min 65.8 ± 9.1 50.4 ± 11.6a 57.7 ± 11.9b
Max 76.6 ± 9.1 62.3 ± 11.3a 68.7 ± 11.4
Knee Min 43.4 ± 9.5 42.1 ± 10.6 42.9 ± 11.0
Max 109.0 ± 14.1 89.8 ± 15.7a 92.5 ± 16.0a
Ankle Min 75.9 ± 4.1 100.7 ± 12.5a 98.1 ± 12.7a
Max 127.4 ± 8.7 129.0 ± 12.1 138.1 ± 11.5a,b
ROM of ankle (°) 51.5 ± 8.0 28.3 ± 11.3a 40.0 ± 16.3b
Shoulder Min 68.5 ± 6.7 78.7 ± 9.5a 76.2 ± 8.5
Max 80.6 ± 8.9 93.8 ± 10.3a 87.7 ± 9.2a,b
Elbow Min 54.2 ± 9.1 58.1 ± 7.4 52.7 ± 8.4 b
Max 119.3 ± 9.7 115.7 ± 7.2 114.4 ± 10.7
Joint angles during the swing phase (°)
Hip Min 62.3 ± 8.5 45.3 ± 12.0a 53.6 ± 12.0b
Max 70.6 ± 8.0 57.7 ± 10.5a 64.0 ± 11.3b
Knee Min 41.0 ± 8.8 39.6 ± 8.9 39.8 ± 9.4
Max 109.0 ± 14.1 89.5 ± 16.0a 92.3 ± 16.0a
Ankle Min 60.7 ± 6.2 96.7 ± 15.3a 86.5 ± 15.2a,b
Max 112.7 ± 9.1 120.4 ± 12.3 125.7 ± 9.0a
ROM of ankle (°) 52.0 ± 7.9 23.6 ± 9.5a 39.2 ± 16.4b
Shoulder Min 67.9 ± 7.5 78.0 ± 10.1 74.6 ± 8.2
Max 81.2 ± 9.8 93.5 ± 10.7a 86.6 ± 9.3b
Elbow Min 50.4 ± 8.2 53.7 ± 5.8 48.3 ± 6.8b
Max 118.0 ± 10.9 112.6 ± 8.6 114.0 ± 11.8
Parameters were measured in control (n = 8) and adjuvant-induced arthritis
(AIA) rats (n = 18) at day 195 post-immunization. The more and less impaired
hemibodies corresponded to hemibodies with the highest and lowest
hind-paw diameter just before locomotion recording, respectively. Values are
means ± SD. aSignificantly different from control rats (p <0.05). bSignificantly
different from the more impaired hemibody (p <0.05). ROM range of motion
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with trends towards a position further to the side for
both fore-limbs and hind-limbs. This abnormality was
significantly more pronounced in the more than in
the less impaired hind-limb. Maximal paw elevation
(Fig. 3b) during the swing phase was significantly
higher in AIA than in control rats, at least for the hind-
limbs, whatever the hemibody considered. In addition,
as shown in Fig. 3c, the ROM of the lateral roll angle
was significantly higher in AIA than in control rats,
reflecting a greater waddling gait in AIA rats. Finally,
the sagittal tilt of the body (Fig. 3d) was significantly
higher in AIA than in control rats, indicating that AIA
rats walked with a higher position of the hindquarters
with respect to the head position.Radiographic score reveals joint damage and new bone
formation in long-term AIA
The radiographic score in AIA rats reached 8.6 ± 3.7 for
joint degradation and 7.8 ± 3.7 for new bone formation.
Fig. 4 illustrates the dramatic dense ossification in the
tarsal region, calcaneum or lower extremity of the tibia
with destruction inside joints in AIA. The global radio-
graphic score (joint degradation + new bone formation),
which was 0.9 ± 0.8 in control rats, reached 10.3 ± 4.1
for the more impaired hemibody and 6.1 ± 4.1 for the
opposite hemibody (p <0.01, not shown).
As shown in Fig. 5, the global radiographic score corre-
lated positively with the arthritis score of the correspond-
ing hind paw measured either at day 22 (Fig. 5a) or at day
195 (Fig. 5b) after AIA induction. Likewise, significant cor-
relation was found between the global radiographic score
and paw diameter of the corresponding hind-paw mea-
sured either at day 22 (r = 0.627, p = 0.003) or at day 195
(r = 0.890, p <10-5, not shown) after AIA induction. The
global radiographic score also correlated negatively with
the ROM of the ankle measured either during the stance
(Fig. 5c) or the swing phase (Fig. 5d). Notably, this nega-
tive correlation was still observed when ROM of ankle
was plotted against the joint degradation score (r = −0.710
and r = −0.727 for the stance and the swing phase, re-
spectively, p <10-5) and against the new bone formation
score (r = −0.852 and r = −0.858 for the stance and the
swing phase, respectively, p <10-5, not shown).
Abnormalities in locomotion are associated with reduced
ankle mobility
Suspecting an association between reduced ankle mobility
and impaired locomotion-related parameters in AIA rats,
we plotted the values of each individual ROM of the ankle
joint (measured either during the stance or swing phase)
against the individual ROM of other joint angles in the
corresponding phase of the cycle. The results are summa-
rized in Table 3. During the stance phase, only the ROM
at the knee correlated significantly with the ROM at the
ankle. By contrast, during the swing phase, the ROM at
the ankle was correlated negatively with the ROM at the
hip, but was positively correlated with the ROM at the
knee and the ROM at the elbow. No association was
found between the ROM at the ankle and the ROM at the
shoulder. The ROM of the ankle either during the stance
or the swing phase correlated negatively with maximal
hind-paw elevation and lateral hind-paw location at toe
off while it correlated positively with the duration of the
stance phase for the hind-limbs.
Reduced ankle mobility was associated with intensity of
initial inflammation
To assess the prognostic value of the intensity of initial
inflammation on long-term locomotor disability, we
Fig. 2 Effect of adjuvant-induced arthritis (AIA) on joint angles. a Angular excursion: dashed and solid lines correspond to values measured in
representative control and AIA rats at day 195 post-immunization, respectively. The phases of the locomotor cycle were normalized (the stance
phase is in gray). b Corresponding stick diagrams of one complete step cycle (stance and swing) in control and AIA rats. Horizontal arrows
indicate the direction of the movement; downward arrows indicate foot contact and upward arrows indicate foot lift
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hind-paw diameter of each hind-limb at days 14, 22 and
30 post-immunization and the corresponding ROM of
the ankle measured at day 195 during both the stance
and swing phase (Fig. 6). During the stance phase
(Fig. 6a), the arthritis score at days 14, 22 and 30 (upper
graph) correlated negatively with the ROM of the ankle.
A negative correlation was also found between hind-paw
diameter at days 14, 22 and 30 and the ROM of the
ankle (bottom graph). Similar results were obtained for
the swing phase (Fig. 6b).
Discussion
Using the AIA model, the present study revealed a
strong association between the intensity of initial symp-
toms of inflammation and the locomotor parameters
measured at day 195 post-immunization. It also found anegative correlation between ankle mobility and concur-
rent hind paw radiographic lesion severity.
Unlike previous studies on AIA rats, which mainly
focused on the acute period after immunization, the
present study is the first to perform long-term follow-up
of the disease in AIA rats (from immunization up to 7
months). Contrary to the general belief that the AIA
model is monophasic [7], but consistent with arthritis
flares in RA patients, our results revealed that 83 % of
rats demonstrated recurrent disease. However, as re-
lapses did not occur at the same time (from week 6 to
week 23) in the population of AIA rats, analysis of the
time course of the global arthritis score failed to detect
them. Moreover, evidence of strong positive correlations
between the global arthritis score (calculated from the
four paws) and hind-paw diameter (calculated from the




















































Fig. 3 Effect of adjuvant-induced arthritis (AIA) on paw location and posture. a Lateral paw location of hind-limbs and fore-limbs, b maximal paw
elevation of hind-limbs and forelimbs, c range of motion (ROM) of lateral tilt and d sagittal tilt were measured in control (n = 8) and AIA rats
(n = 18) at day 195 post-immunization. Values are means ± SD: *p <0.05, **p <0.01
Mossiat et al. Arthritis Research & Therapy  (2015) 17:184 Page 8 of 12day 22 (peak of inflammation) and day 30 (onset of in-
flammation resolution) advocate the use of hind-paw
diameter as an objective and rapid quantification of clin-
ical inflammation in AIA rats, at least in the acute
period after immunization. Thereafter, though the global
arthritis score progressively decreased, hind-paw diam-
eter remained elevated. Thus, hind-paw diameter during
and beyond the resolution of the first inflammatory epi-
sode has to be seen as an index of new bone formation.Fig. 4 Radiographic changes in long-term adjuvant-induced arthritis (AIA).
AIA rats (b and c) at day 195 post-immunization. Note the severe new bon
extremity of tibia (c) in AIA ratsA strong positive association was consistently observed
between the radiographic score and concurrent hind-
paw diameter at day 195 post-immunization. Bone
proliferation and the tendency for joint ankylosis in
AIA rats were previously reported at 4 months post-
immunization [24]. However, these data have gained
little attention as new bone formation is not a feature of
RA. By contrast osteoproliferation is frequent in spondy-
loarthritic patients, suggesting that AIA in its late phaseRepresentative radiographs of the hind-paw from control rats (a) and
e formation in the tarsal region and calcaneum (b) and in the lower
Radiographic score at day 195
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Fig. 5 Radiographic score was associated with the arthritis score and range of motion (ROM) of the ankle. In rats with adjuvant-induced arthritis
(n = 18), global radiographic scores (joint degradation + new bone formation) measured at day 195 were plotted against arthritis scores of
corresponding hind-paws at day 22 (a) and at day 195 (b) post-immunization and against the corresponding ROM of the ankle measured during
the stance (c) or the swing phase (d)
Mossiat et al. Arthritis Research & Therapy  (2015) 17:184 Page 9 of 12could be a relevant model of structural damage associ-
ated with spondyloarthritis.
The present study provides for the first time a com-
prehensive analysis of locomotion in an animal model of
RA. It clearly identified reduced ankle mobility as a
driver of locomotor abnormalities (Table 3). These data
are in line with clinical studies that reported the involve-
ment of impaired mobility of the foot-ankle complex in
the walking disability of RA patients [1, 25–28]. Al-
though it was not in the scope of our study to explainTable 3 Correlation between the ROM of the ankle joint and
other locomotion-related parameters





r p r p
ROM of hip joint (°) −0.176 0.152 −0.288 0.044
ROM of knee joint (°) 0.355 0.017 0.341 0.021
ROM of shoulder joint (°) −0.277 0.051 −0.212 0.107
ROM of elbow joint (°) 0.243 0.077 0.386 0.010
Maximal hind-paw elevation (mm) −0.454 0.003 −0.443 0.003
Lateral hind-paw location (mm) −0.398 0.008 −0.440 0.004
Hind-limb stance duration (ms) 0.387 0.010 0.308 0.034
Parameters were measured in rats with adjuvant-induced arthritis (n = 18) at
day 195 post-immunization. Values are means ± SD. ROM range of motion,
r Pearson’s correlation coefficientthe mechanisms involved in AIA-induced locomotor im-
pairment, the following scenario could be surmised. The
limitation of plantar flexion during the swing phase
forces AIA rats to further elevate their hind-paws to pre-
vent their contact with the treadmill belt and subsequent
stumbles. This adaptive strategy compromises balance
thereby activating compensatory strategies including the
use of the tail as an additional limb and a wider position
of the limbs at toe-off. The exaggerated sagittal tilt of
the body during locomotion could be interpreted as a pos-
tural change to shift body weight towards the fore-limbs
in order to reduce weight-bearing on painful ankles. Like-
wise, the negative correlation between the ROM of the
ankle and stance phase duration supports the idea that
AIA rats try to alleviate the compressive force applied to
the damaged ankles. Finally, evidence of a waddling gait in
AIA rats may reflect exaggerated hind paw elevation dur-
ing the swing phase and accompanying changes in pelvic
girdle mobility.
Factors associated with walking disability in RA pa-
tients in remission have been poorly studied. Pain, lim-
ited joint ROM, loss of functional balance or muscle loss
are all thought to contribute to walking disability in RA
[1–4]. Consistent with a link between evidence of dam-
age on x-ray and functional disability in late RA [28–30],
our results demonstrated strong correlation between
joint degradation and concurrent ROM of the ankle in
AIA rats. The new finding is that ankle mobility
































































































Paw diameter at day 14 Paw diameter at day 22 Paw diameter at day 30
Arthritis score at day 14 Arthritis score at day 22 Arthritis score at day 30





















Fig. 6 The range of motion (ROM) of the ankle was associated with the severity of the first signs of inflammation. In rats with adjuvant-induced
arthritis the individual values of the ROM of the ankle at day 195 post-immunization were plotted against individual arthritis scores or hind-paw
diameters of the corresponding hind-paws measured at day 14, 22 and 30 post-immunization. The ROM of the ankle was measured during the
stance (a) and the swing phase (b)
Mossiat et al. Arthritis Research & Therapy  (2015) 17:184 Page 10 of 12measured in the late phase of AIA correlated negatively
with the arthritis score and with the hind-paw diameter
when measured during the first inflammatory episode,
thus, highlighting the predictive value of early clinical
inflammation for long-lasting problems in arthritis-
associated locomotion. These correlations were observed
not only at the peak of inflammation (day 22) but also at
the onset of clinical symptoms (day 14).
These data have both therapeutic and methodological
perspectives. From a therapeutic perspective, they sug-
gest that the intensity of initial symptoms of inflam-
mation may provide information on the likely motor
outcome in RA patients. In these conditions, the
efficient control of inflammation as early as possible in
RA patients is expected to be the best way to prevent
motor disabilities. As conventional or biological disease-modifying anti-rheumatic drugs (DMARDs) cannot be
initiated before RA diagnosis, the early blockade of in-
flammation can be achieved only with anti-inflammatory
drugs. In agreement with the use of corticoids to deal
with the first signs of inflammation, the early adminis-
tration of corticoids decreases inflammatory symptoms
in animal models of RA [31, 32]. However, further ani-
mal studies are needed to investigate whether early cor-
ticotherapy at a dosage able to treat clinical symptoms
of inflammation translates into positive effects on long-
term locomotor outcome.
Our results clearly emphasize the importance of early
anti-inflammatory therapy to prevent locomotor prob-
lems associated with arthritis. However, physical disabil-
ities, including decreased locomotor activity, remain a
complaint in RA patients in remission. These patients
Mossiat et al. Arthritis Research & Therapy  (2015) 17:184 Page 11 of 12might benefit from the development of strategies that
target processes other than inflammation. Among these
strategies, there is an increasing interest in physical exer-
cise (which targets neuromuscular plasticity) [33, 34],
drugs able to repair joint damage (which target osteo-
blast/osteoclast imbalance) [35] and glucocorticoids at
dosage levels too low to affect the clinical inflammation
itself but with a joint-protective effect (unknown targets)
[36]. Our results provide methodological perspectives
for screening the efficacy of these strategies on motor
function in AIA rats. Such strategies need to be initiated
after resolution of the acute period of inflammation (to
mimic remission in RA patients). As the intensity of the
initial inflammation has a predictive value for long-term
locomotor outcomes in AIA rats, a simple measurement
of paw diameter at the onset of inflammation will allow
the early selection of rats with respect to locomotor out-
comes. This procedure of selection would increase intra-
group homogeneity before randomization of AIA rats
into treated and untreated groups and would provide
the possibility to reveal significant effects of treatments
on locomotor disability.
Conclusion
The present study is the first to carry out long-term fol-
low up of clinical signs of inflammation and provide a
comprehensive analysis of locomotion at the late phase
of the widely used AIA model. The results demonstrate
the predictive value of the intensity of the first inflam-
matory event for long-term locomotor outcome.
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